Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market
Holding EGRX?
Track your performance easily

Eagle Pharmaceuticals (EGRX) Financial Statements

208 Followers

Eagle Pharmaceuticals Financial Overview

Eagle Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.91; its P/E ratio is 0.93; Eagle Pharmaceuticals is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 64.65M$ 66.31M$ 60.70M$ 65.90M$ 74.14M
Gross Profit$ 47.79M$ 49.01M$ 42.46M$ 42.25M$ 50.47M
EBIT$ 10.75M$ 11.75M$ 15.28M$ -2.52M$ -5.32M
EBITDA$ 16.33M$ 17.31M$ 21.36M$ 1.79M$ -3.23M
Net Income Common Stockholders$ 5.16M$ 5.75M$ 8.16M$ -7.13M$ -9.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.35M$ 21.90M$ 55.32M$ 15.38M$ 36.56M
Total Assets$ 404.82M$ 414.18M$ 406.16M$ 386.45M$ 381.76M
Total Debt$ 70.19M$ 76.33M$ 62.47M$ 64.77M$ 53.59M
Net Debt$ 54.84M$ 54.43M$ 7.14M$ 49.39M$ 17.03M
Total Liabilities$ 152.78M$ 171.33M$ 172.60M$ 154.67M$ 143.77M
Stockholders Equity$ 252.04M$ 242.84M$ 233.56M$ 231.78M$ 237.98M
Cash Flow-
Free Cash Flow$ -132.00K$ -33.57M$ 37.55M$ -13.24M$ 42.99M
Operating Cash Flow$ -126.00K$ -33.51M$ 37.56M$ -13.24M$ 42.99M
Investing Cash Flow$ -6.00K$ -12.56M$ -9.00K$ -11.24M$ -75.42M
Financing Cash Flow$ -6.41M$ 12.65M$ 2.39M$ 3.30M$ -536.00K
Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

Eagle Pharmaceuticals Debt to Assets

Eagle Pharmaceuticals Cash Flow

Eagle Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis